Tumoroids, also known as cancer organoids, are patient-derived cancer cells grown as 3D, self-organized multicellular structures. Their biological relevance makes them highly predictive tools for drug and diagnostic development compared to 2D models. However, deriving and expanding tumoroids requires specialized cell biology expertise and a significant amount of time and effort.
Join Discovery Life Sciences at ESMO 2024 September 13-17, 2024 | Fira Barcelona Gran Via, Barcelona, Spain Visit Discovery at Booth #338 Schedule a Meeting at ESMO
Join Discovery Life Sciences at ISSX North America 2024 September 15-18, 2024 | Hilton Hawaiian Village Waikiki Beach Resort, Honolulu, Hawaii Visit Discovery at Booth #113 You are also invited to Discovery's Breakfast Symposium during the Annual ISSX/JSSX Meeting Day 2, Sep 17, 7:15-8:13am Title: Recent Advances in Human Hepatocyte Technologies for Drug Discovery & […]
Visit us at Booth #38 during the 9th CAR-TCR Summit Meeting, September 16-18 at Boston's Hynes Convention Center. You are also invited to our presentation on Day 1, Wednesday Sep 18 at 12:05 pm at the Supply Chain & Clinical Operations Track. “Overcoming the Challenges of PBMC Isolation in a GMP Manufacturing Workflow” Presented by […]
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
